Aurinia Announces Positive Topline Results From the AURORA 2 Con

AUPH: Aurinia Pharmaceuticals Inc.
2021-12-09 06:15:00
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)